SCHEMBL2807248

SCHEMBL2807248

Cc1ccc(Br)cc1CCl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 2/20 0.36
PON1 P27169 1/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPK1 P28482 1/20 0.34
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
TP53 P04637 1/20 0.33
SLC6A4 P31645 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC6A2 P23975 1/20 0.33
CCR5 P51681 1/20 0.33
LMNA P02545 1/20 0.32
HTR2A P28223 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831861 1.00 PYCR1 (0.36) PYCR1PON1ALDH1A1MAPK1POLB
SCHEMBL606473 0.82 PTGDR2 (0.44) PYCR1ALDH1A1MAPK1MAPTFFAR4
SCHEMBL29418547 0.82 PYCR1 (0.47) PYCR1PON1ALDH1A1MAPK1MAPT
SCHEMBL12053 0.82 PYCR1 (0.47) PYCR1PON1ALDH1A1MAPK1MAPT
SCHEMBL8365116 0.79 SMN1; SMN2 (0.41) PYCR1ALDH1A1MAPK1POLBMAPT
SCHEMBL2867783 0.79 CA1 (0.38) PYCR1ALDH1A1MAPK1POLBMAPT
SCHEMBL1561687 0.78 CYP2A6 (0.35) PYCR1ALDH1A1MAPK1POLBPTGDR2
SCHEMBL14363073 0.77 PYCR1 (0.36) PYCR1ALDH1A1MAPK1POLBMAPT
SCHEMBL2550855 0.77 CYP2A6 (0.44) PYCR1ALDH1A1MAPK1POLBMAPT
SCHEMBL21573669 0.77 PYCR1 (0.36) PYCR1ALDH1A1MAPK1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107011316-A A kind of preparation method of 2 [(aminomethyl phenyl of 5 bromine 2) methyl] 5 (4 fluorophenyl) thiophene 上海微巨实业有限公司 2017-08-04 CN claimed
US-20260028330-A1 HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF LIMINAL BIOSCIENCES LTD (GB) 2026-01-29 US disclosed
US-12378200-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2025-08-05 US disclosed
US-20250145572-A1 Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors ORSOBIO INC (US) 2025-05-08 US disclosed
EP-3782996-B1 NRF2 REGULATORS GLAXOSMITHKLINE IP DEV LTD (GB) 2024-04-10 EP disclosed
CN-110536885-B Process for producing difluoromethylene compound 佐藤制药株式会社 2024-03-08 CN disclosed
US-20240059657-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS OrsoBio Inc. 2024-02-22 US disclosed
WO-2024028363-A1 HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF Liminal Biosciences Limited (GB) 2024-02-08 WO disclosed
WO-2024028363-A1 HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF Liminal Biosciences Limited (GB) 2024-02-08 WO disclosed
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
CN-101563322-A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators SMITHKLINE BEECHAM CORPORAITON (US) 2009-10-21 CN disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed
US-4990716-A Preparation of diphenylmethanes THE DOW CHEMICAL COMPANY (US) 1991-02-05 US disclosed
US-4117019-A MANUFACTURE OF O-BENZYLTOLUENES BASF AKTIENGESELLSCHAFT (DE) 1978-09-26 US disclosed
US-3978144-A MANUFACTURE OF O-BENZYLTOLUENES BASF AKTIENGESELLSCHAFT (DT) 1976-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378200-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 PYCR1 155/4885PON1 665/4885ALDH1A1 370/4885
US-20250145572-A1 Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors ACMSD, ALDH7A1, ALAD PYCR1 311/4885PON1 683/4885ALDH1A1 271/4885
US-20240059657-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ALDH7A1, ACMSD, AMD1 PYCR1 155/4885PON1 665/4885ALDH1A1 370/4885
US-20260028330-A1 HETEROARYL CARBOXAMIDE AND RELATED GPR84 ANTAGONISTS AND USES THEREOF GPR84, GPR88, GPR68 PYCR1 1135/4885PON1 2856/4885ALDH1A1 1033/4885
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 PYCR1 155/4885PON1 665/4885ALDH1A1 370/4885
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG PYCR1 278/4885PON1 2552/4885ALDH1A1 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.